February 5th 2024
Paris, February 5, 2024 – 5:45 pm CET
CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aimed at providing a therapeutic alternative for patients suffering from advanced biventricular heart failure (the “Company” or “CARMAT“), today announces its indicative financial calendar for 2024.
This preliminary agenda may be modified. Each publication will be released before market opening.
|
Event |
Date |
|
2023 Full-Year Results |
Wednesday, April 24, 2024 |
|
Shareholders’ Meeting |
Thursday, May 30, 2024 |
|
2024 Half-Year Results |
Wednesday, September 11, 2024 |